Why Effervescent Tablet Manufacturing Matters for Supplement Brands
At SREKE, we understand that effervescent tablets are one of the fastest-growing segments in the dietary supplement market. According to a 2023 Grand View Research report, the global effervescent tablet market is projected to reach USD 28.5 billion by 2030, driven by consumer demand for convenient, fast-absorbing delivery formats. For supplement brand owners and distributors, sourcing a reliable OEM/ODM partner is critical to capturing this opportunity. Common challenges include achieving stable effervescence without moisture degradation, ensuring uniform active ingredient distribution, and navigating regulatory compliance across markets like the US (FDA) and EU (EFSA). At SREKE, we address these challenges head-on with our dedicated effervescent production line.
Key Manufacturing Considerations at SREKE
Formulation Expertise
Effervescent tablets require precise ratios of acid (citric, tartaric) and base (sodium bicarbonate) to ensure rapid dissolution and palatability. Our R&D team designs formulations that mask bitter flavors while maintaining stability—critical for high-potency ingredients like vitamin C, magnesium, or zinc. We use moisture-resistant direct compression methods, and all excipients are food-grade and sourced from approved suppliers.
Dosage Forms and Stability
We produce effervescent tablets in standard diameters (20-25 mm) or custom shapes. Our controlled environment (≤25% RH, 20-25°C) prevents premature reaction during production. Each batch undergoes accelerated stability testing (ICH guidelines) to ensure a shelf life of 24 months.
Quality Standards
Our facility is GMP-certified under ISO 9001:2015 and HACCP. We perform in-process checks on tablet weight, hardness, friability, and dissolution time. Every lot ships with a Certificate of Analysis (COA) from our third-party lab, testing for identity, potency, heavy metals, and microbial limits per USP <61>/<62>.
Regulatory Compliance
We support FDA-registered facilities and EFSA Novel Food compliance. For US brands, we ensure cGMP requirements (21 CFR Part 111) are met. For EU, we provide stability data and can adapt formulations to comply with EFSA health claim rules.
How SREKE Helps You Get to Market Faster
Our OEM/ODM Process
From concept to delivery, SREKE streamlines effervescent tablet production. Our process: (1) Brief and formulation development (2-3 weeks), (2) prototyping and sensory evaluation, (3) scale-up and stability testing (3-4 weeks), (4) commercial production and packaging (MOQ: 50,000 tablets per SKU). Lead time: 45-60 days from approved prototype.
What Sets Us Apart
We invest in specialized effervescent tableting presses with moisture-controlled chambers. Our team provides end-to-end support, including blister packaging (aluminum/aluminum for moisture barrier), tube packaging, and custom labeling. We also offer private label with your branding.
Support from Concept to Delivery
Our project managers guide you through flavor optimization, sweetener selection (stevia, erythritol), and claim substantiation. We also recommend packaging with desiccant liners to extend shelf life during logistics.
Industry Trends and Market Opportunities
Consumer demand for effervescent supplements is rising, especially for immune support, hydration, and energy. A 2024 Nutraceutical Business Review survey found 68% of consumers prefer effervescent tablets over standard tablets due to faster absorption and flavor. Brands can differentiate by targeting specific demographics: fitness enthusiasts (electrolyte effervescents), aging adults (calcium + vitamin D), or travelers (convenient single-serve sticks). At SREKE, we help you create unique formulations, such as low-sugar, organic, or vegan-certified options, to capture niche markets.
Frequently Asked Questions
What is the minimum order quantity (MOQ) for effervescent tablets at SREKE?
Our MOQ for effervescent tablets is 50,000 tablets per SKU. For custom formulations or blister packaging, we can discuss lower quantities for pilot runs.
How do you ensure moisture stability during production and shipping?
We maintain production at ≤25% relative humidity, use desiccant blisters, and package in aluminum-aluminum foil. Each batch is tested for dissolution time under varied humidity conditions to guarantee performance.
Can you help with regulatory documentation for FDA or EFSA?
Yes. We provide a comprehensive regulatory dossier including raw material spec sheets, stability data, and COAs. Our formulations are designed to meet FDA 21 CFR Part 111 and EFSA requirements.
What is the typical lead time from order to delivery?
Lead time is 45-60 days after prototype approval. This includes raw material procurement, production, packaging, and QC testing. Rushed orders may be accommodated with a surcharge.
Ready to launch your supplement brand? SREKE provides GMP-certified OEM/ODM manufacturing for softgels, capsules, tablets, powders, gummies, and liquids. Contact us for a free quote or email [email protected] — we respond within 24 hours.
Visit our factory: SREKE Supplements, Guangzhou, China. www.sreke.com | OEM/ODM/Private Label | Low MOQ | Fast Lead Times